BC Cancer Competitors and Similar CompaniesClear all

BC Cancer's competitors and similar companies include Indivumed, American Cancer Society, Psnresearch and Kinese Fysiotherapeuten.

	BC Cancer BC Cancer is a provider of a province-wide cancer control program in partnership with regional health authorities.	Indivumed Indivumed is an oncology company developing individualized cancer therapy.	American Cancer Society American Cancer Society (ACS) is an organization that specializes in cancer prevention.	Psnresearch Psnresearch is a provider of clinical development service.	Kinese Fysiotherapeuten Kinese Fysiotherapeuten is a provider of healthcare services.
Founding Date	Founding Date 1938	Founding Date 2002	Founding Date 1913	Founding Date 1997	Founding Date N/A
Type	Type Private	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare clinical research medical diagnostics oncology therapy	Tags Healthcare clinical research oncology therapy	Tags Healthcare clinical research oncology therapy	Tags Healthcare clinical research oncology therapy	Tags Healthcare clinical research medical diagnostics oncology rehabilitation therapy
Locations	Locations Vancouver, CA HQ	Locations Hamburg, DE HQ Frederick, US	Locations Kennesaw, US HQ Hagatna, GU Arecibo, PR Caguas, PR Mayagüez, PR Ponce, PR San Juan, PR see more	Locations Charlottesville, US HQ Crows Nest, AU Santiago, CL Glostrup, DK Lyon, FR München, DE Genova, IT see more	Locations Delfzijl, NL HQ
Employees	Employees 2,4391% increase	Employees 964% decrease	Employees 7,754	Employees 24	Employees 25
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €13m (FY, 2020)	Revenue (est.) $768.1m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods €8.2m (FY, 2020)	Cost of goods $442.5m (FY, 2021)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €4.8m (FY, 2020)	Gross profit $325.6m (FY, 2021)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income (€21.2m) (FY, 2020)	Net income $69.3m (FY, 2021)	Net income N/A	Net income N/A